FDA Inspection 1242355 - GlaxoSmithKline Biologicals - June 04, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on June 4, 2024, issued by the Office of Inspections and Investigations, covering biologics.

Company: GlaxoSmithKline Biologicals
Inspection Date: June 4, 2024
Product Type: Biologics
Office: Office of Inspections and Investigations

Open in Dashboard

ID · d49a123e-56fe-42c7-90d1-25abdeb6261d